Pacific Edge Limited (PEB.AX)
AUD 0.11
(0.0%)
AUD 0.11
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -32.19 Million NZD | -19.41% |
| 2023 | -26.96 Million NZD | -36.27% |
| 2022 | -19.78 Million NZD | -39.13% |
| 2021 | -14.22 Million NZD | 24.69% |
| 2020 | -18.88 Million NZD | -5.4% |
| 2019 | -17.91 Million NZD | 8.79% |
| 2018 | -19.64 Million NZD | 6.37% |
| 2017 | -20.98 Million NZD | -33.83% |
| 2016 | -15.67 Million NZD | -46.11% |
| 2015 | -10.72 Million NZD | -7.82% |
| 2014 | -9.95 Million NZD | -43.86% |
| 2013 | -6.91 Million NZD | -69.62% |
| 2012 | -4.07 Million NZD | -30.58% |
| 2011 | -3.12 Million NZD | -23.54% |
| 2010 | -2.52 Million NZD | -2.18% |
| 2009 | -2.47 Million NZD | -28.99% |
| 2008 | -1.91 Million NZD | -1.98% |
| 2007 | -1.88 Million NZD | 25.27% |
| 2006 | -2.51 Million NZD | 11.63% |
| 2005 | -2.84 Million NZD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | -7.14 Million NZD | 0.0% |
| 2024 Q1 | -7.62 Million NZD | 6.97% |
| 2024 Q2 | -7.62 Million NZD | 0.0% |
| 2024 Q3 | -7.14 Million NZD | 6.35% |
| 2024 FY | -32.19 Million NZD | -19.41% |
| 2023 Q4 | -8.19 Million NZD | 0.0% |
| 2023 FY | -26.96 Million NZD | -36.27% |
| 2023 Q3 | -8.19 Million NZD | -55.08% |
| 2023 Q2 | -5.28 Million NZD | 0.0% |
| 2023 Q1 | -5.28 Million NZD | 2.15% |
| 2022 Q2 | -4.49 Million NZD | 0.0% |
| 2022 Q3 | -5.4 Million NZD | -20.23% |
| 2022 Q4 | -5.4 Million NZD | 0.0% |
| 2022 FY | -19.78 Million NZD | -39.13% |
| 2022 Q1 | -4.49 Million NZD | -26.02% |
| 2021 Q2 | -3.54 Million NZD | 0.0% |
| 2021 Q1 | -3.54 Million NZD | 25.31% |
| 2021 Q4 | -3.56 Million NZD | 0.0% |
| 2021 FY | -14.22 Million NZD | 24.69% |
| 2021 Q3 | -3.56 Million NZD | -0.52% |
| 2020 Q3 | -4.74 Million NZD | -1.15% |
| 2020 FY | -18.88 Million NZD | -5.4% |
| 2020 Q4 | -4.74 Million NZD | 0.0% |
| 2020 Q2 | -4.69 Million NZD | 0.0% |
| 2020 Q1 | -4.69 Million NZD | -2.07% |
| 2019 Q3 | -4.59 Million NZD | -5.51% |
| 2019 FY | -17.91 Million NZD | 8.79% |
| 2019 Q1 | -4.35 Million NZD | 9.22% |
| 2019 Q4 | -4.59 Million NZD | 0.0% |
| 2019 Q2 | -4.35 Million NZD | 0.0% |
| 2018 Q1 | -5.01 Million NZD | 10.97% |
| 2018 FY | -19.64 Million NZD | 6.37% |
| 2018 Q4 | -4.8 Million NZD | 0.0% |
| 2018 Q2 | -5.01 Million NZD | 0.0% |
| 2018 Q3 | -4.8 Million NZD | 4.32% |
| 2017 Q3 | -5.63 Million NZD | 0.3% |
| 2017 Q4 | -5.63 Million NZD | 0.0% |
| 2017 FY | -20.98 Million NZD | -33.83% |
| 2017 Q2 | -5.65 Million NZD | 0.0% |
| 2017 Q1 | -5.65 Million NZD | -30.5% |
| 2016 FY | -15.67 Million NZD | -46.11% |
| 2016 Q4 | -4.33 Million NZD | 0.0% |
| 2016 Q1 | -3.5 Million NZD | 7.96% |
| 2016 Q2 | -3.5 Million NZD | 0.0% |
| 2016 Q3 | -4.33 Million NZD | -23.63% |
| 2015 Q4 | -3.8 Million NZD | 0.0% |
| 2015 FY | -10.72 Million NZD | -7.82% |
| 2015 Q3 | -3.8 Million NZD | -56.74% |
| 2015 Q2 | -2.42 Million NZD | 0.0% |
| 2015 Q1 | -2.42 Million NZD | 2.43% |
| 2014 Q2 | -2.48 Million NZD | 0.0% |
| 2014 Q1 | -2.48 Million NZD | -35.24% |
| 2014 FY | -9.95 Million NZD | -43.86% |
| 2014 Q4 | -2.49 Million NZD | 0.0% |
| 2014 Q3 | -2.49 Million NZD | -0.18% |
| 2013 Q3 | -1.83 Million NZD | 0.0% |
| 2013 Q4 | -1.83 Million NZD | 0.0% |
| 2013 FY | -6.91 Million NZD | -69.62% |
| 2012 FY | -4.07 Million NZD | -30.58% |
| 2011 FY | -3.12 Million NZD | -23.54% |
| 2010 FY | -2.52 Million NZD | -2.18% |
| 2009 FY | -2.47 Million NZD | -28.99% |
| 2008 FY | -1.91 Million NZD | -1.98% |
| 2007 FY | -1.88 Million NZD | 25.27% |
| 2006 FY | -2.51 Million NZD | 11.63% |
| 2005 FY | -2.84 Million NZD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Australian Clinical Labs Limited | 23.93 Million AUD | 234.527% |
| BCAL Diagnostics Limited | -6.4 Million AUD | -403.075% |
| Genetic Signatures Limited | -17.86 Million AUD | -80.258% |
| Genetic Technologies Limited | -12.01 Million AUD | -167.93% |
| Healius Limited | -645.8 Million AUD | 95.014% |
| Imagion Biosystems Limited | -12.47 Million AUD | -158.121% |
| Integral Diagnostics Limited | -60.69 Million AUD | 46.955% |
| INOVIQ Ltd | -6.55 Million AUD | -391.243% |
| Microba Life Sciences Limited | -19.93 Million AUD | -61.485% |
| Monash IVF Group Limited | -6.52 Million AUD | -393.301% |
| Rhythm Biosciences Limited | -6.85 Million AUD | -369.577% |
| Sonic Healthcare Limited | 511.09 Million AUD | 106.3% |